349 related articles for article (PubMed ID: 10215618)
1. Sequence analysis of heparan sulphate and heparin oligosaccharides.
Vivès RR; Pye DA; Salmivirta M; Hopwood JJ; Lindahl U; Gallagher JT
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):767-73. PubMed ID: 10215618
[TBL] [Abstract][Full Text] [Related]
2. Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exosequencing of oligosaccharides.
Kinoshita A; Sugahara K
Anal Biochem; 1999 May; 269(2):367-78. PubMed ID: 10222012
[TBL] [Abstract][Full Text] [Related]
3. Heparin sequencing.
Stringer SE; Kandola BS; Pye DA; Gallagher JT
Glycobiology; 2003 Feb; 13(2):97-107. PubMed ID: 12626406
[TBL] [Abstract][Full Text] [Related]
4. Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin.
Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugiura M; Sugahara K
Biochemistry; 1999 Jan; 38(2):838-47. PubMed ID: 9888825
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal degradation of heparin and heparan sulphate.
Freeman C; Hopwood J
Adv Exp Med Biol; 1992; 313():121-34. PubMed ID: 1442257
[No Abstract] [Full Text] [Related]
6. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
[TBL] [Abstract][Full Text] [Related]
7. Mapping critical biological motifs and biosynthetic pathways of heparan sulfate.
Lawrence R; Kuberan B; Lech M; Beeler DL; Rosenberg RD
Glycobiology; 2004 May; 14(5):467-79. PubMed ID: 15033939
[TBL] [Abstract][Full Text] [Related]
8. Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate: stoichiometry, stabilization, and kinetics.
Lookene A; Chevreuil O; Ostergaard P; Olivecrona G
Biochemistry; 1996 Sep; 35(37):12155-63. PubMed ID: 8810923
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
[TBL] [Abstract][Full Text] [Related]
10. Decorin endocytosis: structural features of heparin and heparan sulphate oligosaccharides interfering with receptor binding and endocytosis.
Hausser H; Kresse H
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):827-35. PubMed ID: 10585870
[TBL] [Abstract][Full Text] [Related]
11. Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates.
Blackhall FH; Merry CL; Lyon M; Jayson GC; Folkman J; Javaherian K; Gallagher JT
Biochem J; 2003 Oct; 375(Pt 1):131-9. PubMed ID: 12812520
[TBL] [Abstract][Full Text] [Related]
12. "Linkage region" sequences of heparins and heparan sulfates: detection and quantification by nuclear magnetic resonance spectroscopy.
Iacomini M; Casu B; Guerrini M; Naggi A; Pirola A; Torri G
Anal Biochem; 1999 Oct; 274(1):50-8. PubMed ID: 10527496
[TBL] [Abstract][Full Text] [Related]
13. Structural studies of heparan sulfate hexasaccharides: new insights into iduronate conformational behavior.
Murphy KJ; McLay N; Pye DA
J Am Chem Soc; 2008 Sep; 130(37):12435-44. PubMed ID: 18722428
[TBL] [Abstract][Full Text] [Related]
14. HABA-based ionic liquid matrices for UV-MALDI-MS analysis of heparin and heparan sulfate oligosaccharides.
Przybylski C; Gonnet F; Bonnaffé D; Hersant Y; Lortat-Jacob H; Daniel R
Glycobiology; 2010 Feb; 20(2):224-34. PubMed ID: 19858171
[TBL] [Abstract][Full Text] [Related]
15. Heparin-like heparan sulfate from rabbit cartilage.
Parra A; Veraldi N; Locatelli M; Fini M; Martini L; Torri G; Sangiorgi L; Bisio A
Glycobiology; 2012 Feb; 22(2):248-57. PubMed ID: 21933839
[TBL] [Abstract][Full Text] [Related]
16. NMR characterization of the interaction between the C-terminal domain of interferon-gamma and heparin-derived oligosaccharides.
Vanhaverbeke C; Simorre JP; Sadir R; Gans P; Lortat-Jacob H
Biochem J; 2004 Nov; 384(Pt 1):93-9. PubMed ID: 15270718
[TBL] [Abstract][Full Text] [Related]
17. Relative susceptibilities of the glucosamine-glucuronic acid and N-acetylglucosamine-glucuronic acid linkages to heparin lyase III.
Chai W; Leteux C; Westling C; Lindahl U; Feizi T
Biochemistry; 2004 Jul; 43(26):8590-9. PubMed ID: 15222770
[TBL] [Abstract][Full Text] [Related]
18. Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and low molecular weight-heparins disaccharides and oligosaccharides.
Galeotti F; Volpi N
J Chromatogr A; 2013 Apr; 1284():141-7. PubMed ID: 23453462
[TBL] [Abstract][Full Text] [Related]
19. New pathway of heparan sulphate degradation. Iduronate sulphatase and N-sulphoglucosamine 6-sulphatase act on the polymer chain prior to depolymerisation by a N-sulpho-glucosaminidase and glycuronidases in the mollusc Tagelus gibbus.
Medeiros MG; Ferreira TM; Leite EL; Toma L; Dietrich CP; Nader HB
Comp Biochem Physiol B Biochem Mol Biol; 1998 Mar; 119(3):539-47. PubMed ID: 9734337
[TBL] [Abstract][Full Text] [Related]
20. Endothelial and fibroblast cell-derived heparan sulphate bind with differing affinity to basic fibroblast growth factor.
Pye DA; Kumar S
Biochem Biophys Res Commun; 1998 Jul; 248(3):889-95. PubMed ID: 9704022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
